In 2023, Yang et al (18) reported that TMEM59L is a key marker gene for predicting lymph node metastasis in CRC patients and further confirmed that its high expression is closely associated with shortened overall survival in CRC patients. Here, TMEM59L is linked to colorectal carcinoma.